CD44 and brain neoplasm: Furthermore, efflux transporter proteins expressed at the BBB, such as P-glycoprotein (Pgp1) [1], present significant problems for the treatment of brain tumors with current chemotherapeutics [12] as they act to pump small hydrophobic chemotherapeutic agents out of the brain.